Blog

3 Dividend Stocks That Just Hiked Their Payouts

If you are an income investor, it is important to consider not just companies that pay dividends but ones that also increase them. Without dividend increases, inflation will chip away at the income

TheMotleyFool

0

How Important is ESG Investing?

ESG investing -- that is, focusing on companies that have responsible environmental, social, and governance practices -- is a major focus among many investors these days. But how important should it

TheMotleyFool

0

2 Numbers That Explain How This Hypergrowth Company Can Make You Rich

Most strategy textbooks tell entrepreneurs they must choose between differentiating themselves with a superior product, great service, or the lowest cost to customers. That trade-off made more sense

TheMotleyFool

0

This Pharma Giant Lost the Vaccine Race, But Its COVID-19 Journey May Not Be Over

Pharmaceutical giant Merck (NYSE: MRK) has been relatively quiet during the COVID-19 pandemic. We saw a few of its peers, Johnson & Johnson and Pfizer, get their COVID-19 vaccines approved for mass

TheMotleyFool

0

How Biden's Capital Gains Proposal Could Hurt the Wealthy

There's a reason famed investing giant and billionaire Warren Buffett pays a lower tax rate on his income than his secretary -- he's able to benefit from the favorable treatment that applies to

TheMotleyFool

0

Is There Any Hope Left for Emergent BioSolutions?

Emergent BioSolutions' (NYSE: EBS) streak as a hot coronavirus stock recently came to an abrupt end, after the company ran into problems with its coronavirus vaccine manufacturing contracts. In a

TheMotleyFool

0

This Upcoming Catalyst Could Send Marijuana Stocks Soaring

Here we go again. The Secure and Fair Enforcement (SAFE) banking bill passed the House earlier this month. If that sounds familiar, it's because it passed the House in 2019, only to end up going

TheMotleyFool

0

Can You Become a Millionaire Retiree With Just an IRA?

Lost your workplace retirement plan? Or maybe you have one, but its high fees and lackluster investment options make it about as appealing as reading the federal tax code? I have good news: You

TheMotleyFool

0

5 Small-Cap Stocks With 60% to 140% Upside, According to Wall Street

For more than a year, investors have been spoiled by an epic rally on Wall Street. After losing 34% of its value in a span of just 33 calendar days in the first quarter of 2020, the benchmark S&P

TheMotleyFool

0

Tesla Q1 Earnings: What You Need to Know

Electric-car maker Tesla (NASDAQ: TSLA) continued to grow rapidly in Q1. The company's total revenue surged 74% year over year, fueled by a 109% year-over-year increase in vehicle deliveries. Net

TheMotleyFool

0

3 Reasons Not to Buy Johnson & Johnson Stock Just Because Its COVID Vaccine Pause Was Lifted

The pause on the administration of Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine has been lifted. Ten days after the U.S. Food and Drug Administration (FDA) and Centers for Disease Control and

TheMotleyFool

0

Is There Any Hope for Inovio?

A year ago, Inovio Pharmaceuticals (NASDAQ: INO) held a leading position in the coronavirus vaccine race. The clinical-stage biotech company launched a clinical trial only a month after Moderna

TheMotleyFool

0

What the Dogecoin Rally Tells Us About Bitcoin

If you had bought $1,000 worth of Dogecoin (CRYPTO: DOGE) on Jan. 1, you would have had $93,127 when the cryptocurrency peaked on April 16. Even though the rally has faded since then, you would

TheMotleyFool

0

Pfizer and BioNTech About to Sign the Biggest Vaccine Supply Deal Ever: Why It's Great News for Investors

The orders for Pfizer (NYSE: PFE) and BioNTech's (NASDAQ: BNTX) COVID-19 vaccine keep flowing in. So far, the two partners have secured supply agreements with the European Union totaling 600 million

TheMotleyFool

0

This Huge Win Could Boost Novavax's Fortunes -- and It Has Nothing to Do With COVID-19

Since early 2020, Novavax (NASDAQ: NVAX) has received a lot of attention due to its efforts to develop a COVID-19 vaccine. That attention is deserved. The biotech's COVID-19 vaccine candidate

TheMotleyFool

0

Forget Coinbase: These Stocks Are Infinitely Smarter Buys

Although all eyes have been on special purpose acquisition companies, or SPACs, for much of the past year, it's actually a traditional initial public offering (IPO) that's currently the hottest new

TheMotleyFool

0

Social Security Confidence Is High -- But Should It Be?

Millions of seniors today rely on Social Security to pay their bills. But will the program manage to continue paying benefits in the future as it does today?

It's questionable. Though Social

TheMotleyFool

0

Starbucks Earnings: 2 Key Metrics to Watch

After four quarters in a row of declining year-over-year revenue growth rates, investors are finally expecting Starbucks (NASDAQ: SBUX) to return to growth as vaccinations ramp up and people are

TheMotleyFool

0

A Stock Market Crash Could Be Looming. Here's Why I'm Not Worried

The last year has been one for the record books, and the stock market has experienced an incredible run. In fact, over the past 12 months, the S&P 500 has earned returns of nearly 50%.

However, the

TheMotleyFool

0